BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA
35 results:

  • 1. Low-dose aspirin use and risk of ovarian cancer: a combined analysis from two nationwide studies in Denmark and Sweden.
    Zheng G; Faber MT; Wang J; Baandrup L; Hertzum-Larsen R; Sundström K; Kjær SK
    Br J Cancer; 2024 May; 130(8):1279-1285. PubMed ID: 38347096
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Bone morphogenetic protein-9 downregulates StAR expression by inducing snail expression via SMAD1/5/8 signaling in human granulosa-lutein cells.
    Liu B; Fu B; Zhou S; Wang H; Bi B; Guo M; Cheng JC; Fang L
    Mol Cell Endocrinol; 2024 Mar; 582():112126. PubMed ID: 38109991
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Single-cell profiling identifies distinct hormonal, immunologic, and inflammatory signatures of endometriosis-constituting cells.
    Shin S; Chung YJ; Moon SW; Choi EJ; Kim MR; Chung YJ; Lee SH
    J Pathol; 2023 Nov; 261(3):323-334. PubMed ID: 37807404
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mortality trends and disease burdens of cervical, endometrial and ovarian cancers from 1981 to 2020 in Taiwan.
    Su SY
    Prev Med; 2023 Jul; 172():107551. PubMed ID: 37211252
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. RNA Sequencing Identifies Novel nrg1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic Drivers.
    Severson E; Achyut BR; Nesline M; Pabla S; Previs RA; Kannan G; Chenn A; Zhang S; Klein R; Conroy J; Sausen M; Sathyan P; Saini KS; Ghosh A; Jensen TJ; Reddy P; Ramkissoon SH
    J Mol Diagn; 2023 Jul; 25(7):454-466. PubMed ID: 37164276
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Macrophages Promote ovarian cancer-Mesothelial Cell Adhesion by Upregulation of ITGA2 and VEGFC in Mesothelial Cells.
    Cho SK; Lee K; Woo JH; Choi JH
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766725
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma.
    Murumägi A; Ungureanu D; Khan S; Arjama M; Välimäki K; Ianevski A; Ianevski P; Bergström R; Dini A; Kanerva A; Koivisto-Korander R; Tapper J; Lassus H; Loukovaara M; Mägi A; Hirasawa A; Aoki D; Pietiäinen V; Pellinen T; Bützow R; Aittokallio T; Kallioniemi O
    Br J Cancer; 2023 Feb; 128(4):678-690. PubMed ID: 36476658
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis.
    Drumond-Bock AL; Bieniasz M
    Mol Cancer; 2021 Nov; 20(1):145. PubMed ID: 34758842
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic
    Odintsov I; Lui AJW; Sisso WJ; Gladstone E; Liu Z; Delasos L; Kurth RI; Sisso EM; Vojnic M; Khodos I; Mattar MS; de Stanchina E; Leland SM; Ladanyi M; Somwar R
    Clin Cancer Res; 2021 Jun; 27(11):3154-3166. PubMed ID: 33824166
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical perspectives of BET inhibition in ovarian cancer.
    Andrikopoulou A; Liontos M; Koutsoukos K; Dimopoulos MA; Zagouri F
    Cell Oncol (Dordr); 2021 Apr; 44(2):237-249. PubMed ID: 33469840
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. nrg1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors.
    Miyake TM; Pradeep S; Bayraktar E; Stur E; Handley KF; Wu SY; Rodriguez-Aguayo C; Lee JS; Lopez-Berestein G; Coleman RL; Sood AK
    Mol Cancer Ther; 2020 Aug; 19(8):1727-1735. PubMed ID: 32499298
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of the key genes associated with chemotherapy sensitivity in ovarian cancer patients.
    Zheng H; Zhang M; Ma S; Yang W; Xie S; Wang Y; Liu Y; Kai J; Ma Q; Lu R; Guo L
    Cancer Med; 2020 Jul; 9(14):5200-5209. PubMed ID: 32441484
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody-dependent HER4 intracellular domain trafficking.
    Lanotte R; Garambois V; Gaborit N; Larbouret C; Musnier A; Martineau P; Pèlegrin A; Chardès T
    Cancer Sci; 2020 Jul; 111(7):2508-2525. PubMed ID: 32415868
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Developing Organoids from ovarian cancer as Experimental and Preclinical Models.
    Maenhoudt N; Defraye C; Boretto M; Jan Z; Heremans R; Boeckx B; Hermans F; Arijs I; Cox B; Van Nieuwenhuysen E; Vergote I; Van Rompuy AS; Lambrechts D; Timmerman D; Vankelecom H
    Stem Cell Reports; 2020 Apr; 14(4):717-729. PubMed ID: 32243841
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. TGF-β1 induces VEGF expression in human granulosa-lutein cells: a potential mechanism for the pathogenesis of ovarian hyperstimulation syndrome.
    Fang L; Li Y; Wang S; Li Y; Chang HM; Yi Y; Yan Y; Thakur A; Leung PCK; Cheng JC; Sun YP
    Exp Mol Med; 2020 Mar; 52(3):450-460. PubMed ID: 32152452
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Granulosa-Lutein Cell Sirtuin Gene Expression Profiles Differ between Normal Donors and Infertile Women.
    González-Fernández R; Martín-Ramírez R; Rotoli D; Hernández J; Naftolin F; Martín-Vasallo P; Palumbo A; Ávila J
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906251
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Detection of nrg1 Gene Fusions in Solid Tumors.
    Jonna S; Feldman RA; Swensen J; Gatalica Z; Korn WM; Borghaei H; Ma PC; Nieva JJ; Spira AI; Vanderwalde AM; Wozniak AJ; Kim ES; Liu SV
    Clin Cancer Res; 2019 Aug; 25(16):4966-4972. PubMed ID: 30988082
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Antihistamine use and risk of ovarian cancer: A population-based case-control study.
    Verdoodt F; Pottegård A; Dehlendorff C; Jäättelä M; Hallas J; Friis S; Kjaer SK
    Maturitas; 2019 Feb; 120():47-52. PubMed ID: 30583764
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Response to ERBB3-Directed Targeted Therapy in
    Drilon A; Somwar R; Mangatt BP; Edgren H; Desmeules P; Ruusulehto A; Smith RS; Delasos L; Vojnic M; Plodkowski AJ; Sabari J; Ng K; Montecalvo J; Chang J; Tai H; Lockwood WW; Martinez V; Riely GJ; Rudin CM; Kris MG; Arcila ME; Matheny C; Benayed R; Rekhtman N; Ladanyi M; Ganji G
    Cancer Discov; 2018 Jun; 8(6):686-695. PubMed ID: 29610121
    [No Abstract]    [Full Text] [Related]  

  • 20. Use of antidepressants and risk of epithelial ovarian cancer.
    Mørch LS; Dehlendorff C; Baandrup L; Friis S; Kjaer SK
    Int J Cancer; 2017 Dec; 141(11):2197-2203. PubMed ID: 28791695
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.